BioWorld

Oct. 18, 2006

View Archived Issues

'Obvious' Buyout: Lilly Paying $2.1B For Cialis Partner ICOS

ICOS Corp., which through a successful joint venture with Eli Lilly and Co. commercialized the erectile dysfunction product Cialis, agreed to be acquired by Lilly in a deal valued at about $2.1 billion. (BioWorld Today) Read More

Roche, InterMune In HCV Deal With $530M Potential

Read More

Genzyme Paying $580M For AnorMED; Millennium Blinks

Read More

Memory's Phase IIa Study On Hold; Firm Raises $26M

Read More

Other News To Note

Read More

Clinic Roundup

Read More